Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Telemedicine and Digital Technologies in Neurological Intractable Diseases].

Brain and nerve = Shinkei kenkyu no shinpo·2026
Same author

Validation of automated image-guided programming in STN-DBS for Parkinson's disease.

Frontiers in human neuroscience·2026
Same author

Inner ear high signal on non‑contrast 3D FLAIR imaging in patients with cerebrospinal fluid leaks: Association with dural/subdural changes and with audiovestibular symptoms.

European journal of radiology open·2026
Same author

Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer.

Cancers·2026
Same author

Dopaminergic medication alters muscle synergy during sit-to-stand motion in Parkinson's disease.

Frontiers in neurology·2026
Same author

Generation of three hiPSC clones from a frontotemporal dementia (FTD) patient with a heterozygous MAPT mutation p.K298_H299insQ (c.896_897insACA).

Stem cell research·2026

Related Experiment Video

Updated: May 5, 2026

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

11.2K

[Update on deep brain stimulation for movement disorders].

Atsushi Umemura1, Genko Oyama, Yasushi Shimo

  • 1Department of Research and Therapeutics for Movement Disorders, Juntendo University.

Rinsho Shinkeigaku = Clinical Neurology
|December 3, 2013
PubMed
Summary

Deep brain stimulation (DBS) offers significant benefits for movement disorders like Parkinson disease (PD) and dystonia. Early DBS introduction may improve long-term outcomes and reduce medication dependence.

More Related Videos

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

10.7K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

25.1K

Related Experiment Videos

Last Updated: May 5, 2026

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

11.2K
Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

10.7K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

25.1K

Area of Science:

  • Neurology
  • Neurosurgery

Context:

  • Deep brain stimulation (DBS) is a key therapy for medically refractory movement disorders.
  • Subthalamic nucleus (STN) and globus pallidus internus (GPi) are primary DBS targets for Parkinson disease (PD).

Purpose:

  • To review the effectiveness of DBS for movement disorders.
  • To highlight recent advancements and target options in DBS therapy.

Summary:

  • DBS improves motor function and quality of life in PD patients, particularly for levodopa-responsive symptoms.
  • STN DBS reduces dopaminergic medication needs, and combined therapy offers prolonged symptom relief.
  • New evidence suggests early DBS intervention may yield better future outcomes.
  • DBS of the Vim thalamus and posterior subthalamic area (PSA) are effective for intractable tremor.
  • GPi DBS is a viable treatment for generalized dystonia.

Impact:

  • DBS provides a valuable therapeutic option for patients with debilitating movement disorders.
  • Advancements in DBS targeting offer expanded treatment possibilities for various neurological conditions.
  • Evidence supports optimizing treatment strategies, including early DBS intervention, for improved patient prognosis.